Passage Bio, Inc. (PASG) Q4 2022 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Passage Bio, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.009 -- 00:00:05.110 Good morning and welcome to the Passage Bio Board Quarter and Full Year 2022 00:00:05.110 -- 00:00:08.111 Financial and Operating Results Conference Call. 00:00:08.111 -- 00:00:11.272 At this time, all participants are in listen-only mode. 00:00:11.272 -- 00:00:15.333 Following the formal remarks, we will open the call-out for your questions. 00:00:15.333 -- 00:00:19.513 Please be advised that this call is being recorded at the company's request. 00:00:19.513 -- 00:00:23.654 Now, I'd like to turn it over to Stuart Henderson, Vice President of Corporate Development 00:00:23.654 -- 00:00:27.695 and Investor Relations. Stuart, please proceed. 00:00:29.892 -- 00:00:33.855 Thank you, Operator. This morning, we issued a press release that outlines the topics 00:00:33.855 -- 00:00:38.479 we plan to discuss today. This release is available on the Passage Bio website under 00:00:38.479 -- 00:00:42.042 the Press Releases and Statements section of Investors & News. 00:00:42.042 -- 00:00:46.246 On today's call, Chief Executive Officer Will Chu will review our fourth quarter 2022 00:00:46.246 -- 00:00:51.350 and recent business highlights. Mark Foreman, our Chief Medical Officer, will review 00:00:51.350 -- 00:00:55.213 our clinical programs, and Simona King, our Chief Financial Officer, will review our 00:00:55.213 -- 00:00:59.075 fourth quarter and full year 2022 financial results. 00:00:59.431 -- 00:01:03.733 Before we begin, please note that today's call may include a number of forward-looking 00:01:03.733 -- 00:01:07.836 statements. These forward-looking statements are based on assumptions that are subject 00:01:07.836 -- 00:01:12.378 to risks and uncertainties that could cause the company's actual results to differ significantly 00:01:12....